Redeye reiterates its positive stance on Heliospectra, even though the Q4-performance was weaker than we expected. We argue that the lower sales in the quarter is an effect of a major strategic shift towards large orders, and expect the company to hit a sales record in 2020, meaning sales growth of +240% y/y.